12/12/2019 Strides Pharma Science Ltd - Screener

Strides Pharma Science Ltd

 

Strides Pharma Science is engaged in develops and manufactures a wide range of IP-led niche pharmaceutical products.

Market Cap:  3,293 Cr.

Current Price:  367.75

52 weeks High / Low  551.40 / 288.00

Book Value:  290.10

Stock P/E: 8.03

Dividend Yield: 0.82 %

ROCE: 10.13 %

ROE: 12.75 %

Sales Growth (3Yrs): 1.73 %

Listed on BSE and NSE

Company Website

Face Value:  10.00

Add Quick Ratio

eg. Promoter holding

1m 3m 6m 1Yr 3Yr 5Yr Max

Price Price to Earning

Pros:
Company has reduced debt.

https://www.screener.in/company/STAR/consolidated/ 1/5
12/12/2019 Strides Pharma Science Ltd - Screener

Cons:
Promoter holding is low: 31.28%
Tax rate seems low
Contingent liabilities of Rs.3315.61 Cr.
Promoters have pledged 51.29% of their holding.
Earnings include an other income of Rs.460.92 Cr.

** Remarks:
Some businesses are provided tax bene ts to encourage their development

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
 EDIT COLUMNS

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Pro t Var % Sales Qtr Rs.Cr. Qtr Sales Var % ROCE %

1. Sun Pharma.Inds. 434.15 24.08 104264.17 0.63 1064.09 57.62 8123.35 17.09 11.19

2. Dr Reddy's Labs 2905.65 17.63 48288.19 0.69 1106.80 113.54 4812.80 26.07 12.42

3. Cipla 461.05 22.55 37191.67 0.65 471.35 25.01 4395.78 9.57 10.94

4. Biocon 292.85 45.02 35142.00 0.17 215.70 -24.60 1572.20 19.02 13.39

5. Piramal Enterp. 1657.75 15.84 32978.68 1.57 554.69 17.26 3603.56 14.61 9.42

6. Torrent Pharma. 1857.60 37.06 31425.87 0.92 244.00 36.31 2005.00 5.86 12.66

7. Cadila Health. 264.00 17.50 27042.27 1.33 107.20 -35.02 3366.60 13.69 15.35

8. Strides Pharma 367.75 8.03 3293.31 0.82 142.72 981.31 715.09 37.62 10.13

Detailed Comparison with:

eg. Infosys

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Dec Mar Jun
Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019
2016 2017 2017

Sales + 730 677 658 769 749 670 663 520 788 840 686 715

Expenses + 591 569 592 676 621 582 591 491 678 723 605 612

Operating Pro t 139 108 66 93 128 88 73 29 110 117 81 104

OPM % 19% 16% 10% 12% 17% 13% 11% 6% 14% 14% 12% 14%

Other Income 155 118 31 10 50 575 6 5 283 46 4 128

Interest 44 48 52 49 50 45 44 17 50 63 35 40

Depreciation 31 38 34 37 38 44 43 31 41 44 43 42

Pro t before tax 220 140 10 17 90 573 -8 -14 303 56 6 149

Tax % 11% 6% 42% 32% 2% -1% 70% 39% 2% 20% 52% 5%

Net Pro t 187 112 1 9 85 569 -4 -12 293 48 4 143

EPS in Rs 20.95 12.57 0.06 0.96 9.55 63.56 -0.48 -1.34 32.77 5.31 0.41 15.94

Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

https://www.screener.in/company/STAR/consolidated/ 2/5
12/12/2019 Strides Pharma Science Ltd - Screener

Dec Dec Dec Dec Dec Dec Mar Mar Mar Mar Mar Mar
TTM
2007 2008 2009 2010 2011 2012 2014 2015 2016 2017 2018 2019

Sales + 744 1,020 1,304 1,695 2,550 962 1,341 1,196 2,861 2,755 2,845 3,012 3,028

Expenses + 822 1,183 1,122 1,385 2,061 861 1,567 988 2,486 2,243 2,458 2,699 2,618

Operating Pro t -78 -163 182 311 489 101 -226 208 374 512 387 313 411

OPM % -10% -16% 14% 18% 19% 10% -17% 17% 13% 19% 14% 10% 14%

Other Income 150 403 86 86 83 959 3,281 896 63 306 654 407 461

Interest 70 85 76 147 195 79 109 47 168 183 196 205 188

Depreciation 36 40 49 64 104 31 56 64 131 126 154 172 169

Pro t before tax -35 115 143 186 273 949 2,890 992 137 509 690 343 514

Tax % -49% 9% 15% 24% 14% 11% 39% 15% 31% 12% 1% 4%

Net Pro t -50 108 110 122 224 846 1,767 845 109 400 665 325 487

EPS in Rs 0.00 26.81 24.45 20.96 38.12 143.59 199.38 134.06 12.00 44.71 74.25 36.25 54.43

Dividend Payout % -0% 0% 6% 7% 5% 1% 170% 76% 41% 10% 3% 8%

* Sales is net of excise duty and discounts

Compounded Sales Growth
10 Years: 11.43%
5 Years: 17.57%
3 Years: 1.73%
TTM: 16.40%

Compounded Pro t Growth

10 Years: 20.52%
5 Years: -28.70%
3 Years: 36.68%
TTM: -37.68%

Stock Price CAGR

10 Years: 5.01%
5 Years: -16.78%
3 Years: -30.63%
1 Year: -20.56%

Return on Equity
10 Years: 32.35%
5 Years: 22.46%
3 Years: 18.50%
Last Year: 12.75%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Dec Dec Dec Dec Dec Dec Mar Mar Mar Mar Mar Mar Sep
2007 2008 2009 2010 2011 2012 2014 2015 2016 2017 2018 2019 2019

Share Capital + 84 89 89 58 58 59 60 60 89 89 90 90 90

Reserves 173 324 724 1,223 1,313 1,967 947 1,085 2,569 2,659 2,374 2,559 2,508

Borrowings 1,277 1,302 1,457 2,010 2,643 1,594 547 892 3,542 3,700 2,520 3,221 1,802

Other Liabilities
548 661 1,013 1,203 1,350 1,177 546 451 1,299 1,657 2,171 2,669 1,589
+

https://www.screener.in/company/STAR/consolidated/ 3/5
12/12/2019 Strides Pharma Science Ltd - Screener

Total Liabilities Dec

2,034 Dec
2,327 Dec
3,234 Dec
4,493 Dec
5,364 Dec
4,798 Mar
2,099 Mar
2,488 Mar
7,499 Mar
8,105 Mar
7,154 Mar
8,539 Sep
5,988
2007 2008 2009 2010 2011 2012 2014 2015 2016 2017 2018 2019 2019
Fixed Assets + 982 970 1,857 2,328 3,188 3,017 555 701 2,679 2,980 2,977 3,645 2,294

CWIP 314 260 85 191 285 241 99 171 815 780 620 506 121

Investments 2 346 341 2 0 0 443 630 1,341 1,525 588 702 559

Other Assets + 736 752 951 1,972 1,892 1,539 1,002 985 2,664 2,821 2,969 3,687 3,015

Total Assets 2,034 2,327 3,234 4,493 5,364 4,798 2,099 2,488 7,499 8,105 7,154 8,539 5,988

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Dec Dec Dec Dec Dec Dec Mar Mar Mar Mar Mar Mar
2007 2008 2009 2010 2011 2012 2014 2015 2016 2017 2018 2019

Cash from Operating

93 118 90 324 454 139 83 73 288 187 60
Activity +

Cash from Investing

-605 -265 -148 -928 -656 771 50 -2,205 -1,222 570 -145
Activity +

Cash from Financing

665 13 92 850 89 -990 -421 2,944 338 -1,016 194
Activity +

Net Cash Flow 153 -133 33 246 -113 -80 -288 812 -596 -259 110

Ratios Consolidated Figures in Rs. Crores / View Standalone

Dec Dec Dec Dec Dec Dec Mar Mar Mar Mar Mar Mar
2007 2008 2009 2010 2011 2012 2014 2015 2016 2017 2018 2019

ROCE % -1% 8% 8% 12% 11% 27% 116% 58% 8% 12% 16% 10%

Debtor Days 103 121 126 92 77 183 99 119 132 132 113 120

Inventory Turnover 4.59 5.45 6.41 6.22 6.44 2.09 4.34 6.23 6.97 4.09 4.43 4.23

Recent Announcements

Announcement under Regulation 30 (LODR)-Change in Directorate Dec. 11, 2019

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Dec. 5, 2019

Announcement under Regulation 30 (LODR)-Press Release / Media Release Dec. 4, 2019

Announcement under Regulation 30 (LODR)-Press Release / Media Release Dec. 4, 2019

Compliances-Reg. 39 (3) - Details of Loss of Certi cate / Duplicate Certi cate Nov. 27, 2019

 VIEW ALL ANNOUNCEMENTS

Annual Reports

Financial Year 2019 from bse

Financial Year 2018 from bse

Financial Year 2017 from bse

Financial Year 2016 from bse

https://www.screener.in/company/STAR/consolidated/ 4/5
12/12/2019 Strides Pharma Science Ltd - Screener

Financial Year 2015 from bse

Financial Year 2014 from bse

Financial Year 2012 from bse

Financial Year 2012 from nse

Financial Year 2011 from bse

Financial Year 2010 from bse

Financial Year 2009 from nse

Financial Year 2008 from nse

Credit Ratings

Strides Pharma Science Limited: Ratings rea rmed and removed from watch with developing implications icra

India Ratings Revises Strides Pharma Science’s Outlook to Positive; A rms ‘IND A’ tch

Strides Pharma Science Limited: Ratings of [ICRA]A+/[ICRA]A1 placed on watch with developing implications icra

India Ratings A rms Strides Pharma Science at ‘IND A’; Outlook Stable tch

Strides Shasun Limited: Rating rea rmed and Negative outlook assigned; ratings removed from watch with developing implications icra

Strides Shasun Limited: Update on Material Event icra

Strides Shasun Limited: Long term rating rea rmed at [ICRA]A+ and short-term rating revised to [ICRA]A1; continues to be on watch with
developing implications icra

ICRA assigns [ICRA]A+ rating to enhanced term loan facilities of Strides Shasun Limited; ratings continue to be on watch with developing
implications icra

ICRA rea rms the [ICRA]A+ / A1+ ratings outstanding on the bank facilities of Strides Shasun Limited; ratings continue to be on watch with
developing implications icra

ICRA places ratings for Strides Shasun Limited on 'rating watch with developing implications' icra

Rating of [ICRA]A1+ assigned to the enhanced bank facilities of Strides Shasun Limited icra

Ratings re-a rmed for the bank facilities of Strides Shasun Limited at [ICRA]A+(Stable)/ [ICRA]A1+ rated amount enhanced, removed from watch
with developing implications icra

https://www.screener.in/company/STAR/consolidated/ 5/5